This study explored the level of antihypertensive medication adherence and examined certain demographic attributes and influential factors in relation to antihypertensive medication nonadherence among Chinese American elders using a descriptive cross-sectional survey design. Findings revealed that 52% of the elderly Chinese Americans adhered to their antihypertensive medications. Gender, education, years of residency in the United States, years of diagnosed hypertension, and perceived safety of taking antihypertensive medications did not contribute to the differences in medication adherence. Forgetfulness, medication adverse effects, language difficulties, and cultural barriers were the influential factors that hinder antihypertensive medication adherence. Developing effective and culturally appropriate strategies for Chinese American elders is recommended.
Bloom, B.S. ( 2001). Daily regimen and compliance with treatment fewer daily doses and drugs with fewer side effects improve compliance. British Medicine Journal, 22, 647-654.
2.
Bramley, T.J., Gerbino, P.P., Nightengale, B.S., & French-Tamas, F. (2006). Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. Journal of Managed Care Pharmacy, 12, 239-245.
3.
Ding, P., Hu, O.Y.-P., Pool, P., & Liao, W.C. ( 2000). Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotesin-converting enzyme inhibitors? Journal of Human Hypertension, 14, 163-170.
4.
Fang, X.H., Zhang, X.H., Yang, Q.D., Dai, X.Y., Su, F.Z., Rao, M.L., . . . Li, S.C. ( 2006). Subtype hypertension and risk of stroke in middle-aged and older Chinese: A 10-year follow up study. Stroke, 37, 38-43.
5.
Federal Interagency Forum. (2006). Older American update 2006: Key indicators of wellbeing. Retrieved from http://www.agingstats.gov/agingstatsdotnet/main_site/default
6.
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Muntner, P., . . . He, J. ( 2002). Prevalence, awareness, treatment, and control of hypertension in China. Hypertension, 40, 920-927.
7.
Hajjar, I., & Kotchen, T.A. ( 2003). Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. Journal of the American Medical Association, 290, 199-206.
8.
Hamilton, G.A. ( 2003). Measuring adherence in a hypertension clinical trial . European Journal of Cardiovascular Nursing, 2, 219-228.
9.
Hershey, J.C., Morton, B.G., Davis, J.B., & Reigchott, M.J. (1980). Patient compliance with antihypertensive medication. American Journal of Public Health , 70, 1081-1089.
10.
Hong, T.B., Oddone, E.Z., Duddley, T., & Bosworth, H.B. (2006). Medication barrier and anti-hypertensive medication adherence: The moderating role of locus of control . Psychology, Health & Medicine, 11, 20-28.
11.
Jang, M., Lee, E., & Woo, K. ( 1998). Income, language, and citizenship: Factors affecting the health care access and utilization of Chinese Americans. Health & Social Work, 23(2), 25-31.
12.
Johnson, M.J. ( 2002). The medication adherence model: A guide for assessing medication taking. Research and Theory for Nursing Practice: An International Journal, 16, 179-192.
13.
Johnson, M.J., & Rogers, S. ( 2006). Development of the purposeful action medication-taking questionnaire. Western Journal of Nursing Research, 28, 335-351.
14.
Johnson, M.J., Williams, M., & Marshall, E.S. (1999). Adherence and non-adherence medication-taking in elderly hypertensive patients. Clinical Nursing Research, 8, 318-335.
15.
Kim, M.T., Hill, M.N., Bone, L.R., & Levin, D.M. ( 2000). Development and testing of the Hill-Bone compliance to high blood pressure scale. Progress in Cardiovascular Nursing , 15, 90-96.
16.
Knight, E.L., Bohn, R.L., Wang, P.S., Glynn, R.J., Mogu, H., & Avon, J. ( 2001). Predictors of uncontrolled hypertension in ambulatory patients. Hypertension, 38, 809-818.
17.
Krousel-Wood, M., Muntner, P., Jannu, A., Desalvo, K., & Re, R.N. ( 2005). Reliability of a medication adherence measure in an outpatient setting. American Journal of the Medical Sciences, 330, 128-133.
18.
Levy, R. ( 1999). Ethnic and racial differences in response to medicines: Preserving individualized therapy in managed pharmaceutical program. Pharmaceutical Medicine, 7, 139-165.
19.
Li, W.W., Stewart, A.L., Stotts, N.A., & Froelicher, E.S. (2005). Cultural factors medication compliance in Chinese immigrants who are taking antihypertensive medications: Instrument development. Journal of Nursing Measurement, 13, 231-252.
20.
Li, W.W., Stewart, A.L., Stotts, N.A., & Froelicher, E.S. (2006). Cultural factors with antihypertensive medication adherence in Chinese Immigrants. Journal of Cardiovascular Nursing, 21, 354-362.
21.
Lowry, K.P., Dudley, T.K., Oddone, E.Z., & Bosworth, H.B. (2005). Intentional and unintentional non-adherence to antihypertensive medication. Annals of Pharmacotherapy , 39, 1198-1203.
22.
Lu, J., Li, L.M., Cao, W.H., Zhan, S.Y., & Hu, Y.H. ( 2003). Post-marketing surveillance of benazepril-related cough and related risk factors analysis on hypertension. Zhonghua Liu Xing Bing Xue Za Zhi, 2, 401-405.
23.
Monane, M., Rhonda, L.B., Gurwitz, J.H., Glynn, R.J., Levin, R., & Avorn, J. ( 1996). Compliance with antihypertensive therapy among elderly Medicaid enrollees: The role of age, gender, and race. American Journal of Public Health, 86, 1805-1808.
24.
Murray, D.M., Morrow, D.G., Weiner, M., Clark, D.O., Tu, W., Deer, M.M., . . . Weinberger, M. (2004). A conceptual framework to study medication adherence in older adults. American Journal of Geriatric Pharmacotherapy, 2, 36-43.
25.
National Institute of Neurological Disorder and Stroke. ( 2006). Stroke: Hope through research. Retrieved from http://www.ninds.nih.gov/disorders/stroke/detail_stroke.htm
26.
Ngo-Metzger, Q., Massagli, M.P., Clarridge, B., Manocchia, M., Davis, R.B., & Phillip, R.S. ( 2003). Linguistic and cultural barriers to care: Perspectives of Chinese and Vietnamese immigrants. Journal of General Internal Medicine, 18, 44-52.
27.
Tomlinson, B., Woo, J., Thomas, N., Chau, Y.-M., & Critchey, A.J.H. (2004). Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult Chinese patient with hypertension. Clinical Therapeutics, 26, 1292-1304.
28.
U.S. Bureau of the Census. (2000). Profiles of general demographic characteristics: 2000 census of population and housing, United States. Washington, DC: U.S. Department of Commerce.
29.
Wang, P.S., Bohn, R.L., Knight, E., Glynn, R.J., Mogum, H., & Avorn, J. ( 2002). Noncompliance with antihypertensive medications: The impact of depression symptoms and psychosocial factors. Journal of General Internal Medicine, 17, 504-511.
30.
Wang, T.J., & Vasan, R.V. ( 2005). Epidemiology of uncontrolled hypertension in the United States. Circulation, 112, 1651-1662.
31.
Wang, Y. ( 2003). People of Chinese heritage. In L. D. Purnell & B. J. Paulanka (Eds.), Transcultural health care (pp. 218-233). Philadelphia, PA: F. A. Davis.
32.
Wong, C.C., Mouanoutoua, V., Chen, M.J., Gray, K., & Tseng, W. ( 2005). Adherence with hypertension care among Hmong Americans . Journal of Community Health Nursing, 22, 143-146.
33.
Woo, K.S., & Nicholls, M.G. (1995). High prevalence of patient cough with angiotensin converting enzyme inhibitors in Chinese. British Journal Clinical Pharmacology, 40, 141-144.
34.
Zhan, L., & Chen, J. ( 2004). Medication practices among Chinese American older adults: A study of cultural influences. Journal of Gerontological Nursing, 30, 24-33.
35.
Zhan, L., Cloutterbuck, J., Kenshian, J., & Lombadi, L. ( 1998). Promoting health: Perspective from ethnic elderly women . Journal Community Health Nursing, 15, 31-44.
36.
Zhou, H.H., Koshakji, R.P., Siberstein, D.J., Wilkinson, G.R., & Wood, A.J. ( 1989). Racial differences in drug response: Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared withAmerican whites. New England Journal of Medicine, 320, 565-570.
